Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy.
Rodríguez-Enríquez F, Costas-Lago MC, Besada P, Alonso-Pena M, Torres-Terán I, Viña D, Fontenla JÁ, Sturlese M, Moro S, Quezada E, Terán C.
Rodríguez-Enríquez F, et al. Among authors: vina d.
Bioorg Chem. 2020 Nov;104:104203. doi: 10.1016/j.bioorg.2020.104203. Epub 2020 Sep 2.
Bioorg Chem. 2020.
PMID: 32932120